BioSpace News Archive

WellCare Health Plans, Inc. reported results for the quarter ended March 31, 2019.

Bolsters capital to advance lead programs into the clinic and broaden early-stage pipeline of therapeutics against previously intractable drug targets

Method includes proprietary, single-step closed-tube NGS library prep in 3 hours or less

First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer Biopharmaceuticals Group and 1% Operational Growth From Upjohn

Alma Lasers a global innovator of laser, light-based, radiofrequency and ultrasound solutions for the aesthetic and surgical markets announces the availability of BeautiFill, the first laser-based procedure pioneered for quick and gentle fat harvesting for patients seeking to address volume loss on the face or body.

REGENXBIO Inc. announced that it will host a conference call on Tuesday, May 7, 2019, at 4:30 p.m. ET to discuss its financial results for the quarter ended March 31, 2019, and recent operational highlights.

VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA clearance for its RX-1 wearable device.

JPMorgan Chase & Co. Chairman and CEO will talk leadership, risk-taking and healthcare

Synlogic’s robust and reproducible lyophilization process provides a solid formulation of SYNB1618 with improved quality attributes, stability and minimal loss of viability compared to liquid formulation

Total revenues of $498 million (+30% vs Q1 2018) and total product-related revenues of $458 million (+20% vs Q1 2018) for the quarter ended March 31, 2019